Advertisement
ADVANCED SEARCH

This Article Figures Only Full Text Full Text (PDF) Résumé Submit a response View responses Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jenkins, D. J.A. Articles by Cunnane, S. C. Search for Related Content PubMed PubMed Citation Articles by Jenkins, D. J.A., MD PhD Articles by Cunnane, S. C., PhD Related Collections Arrhythmias Other cardiovascular medicine Related Articles

Fish-oil supplementation in patients with implantable cardioverter defibrillators: a meta-analysis

From the Clinical Nutrition and Risk Factor Modification Centre (Josse, LaBelle, Kendall) and the Department of Medicine and Divisions of Endocrinology and Metabolism (Jenkins) and Cardiology (Dorian), St. Michael's Hospital, Toronto, Ont.; the Departments of Nutritional Sciences (Jenkins, Josse, LaBelle, Kendall) and Biostatistics (Beyene), University of Toronto, Toronto, Ont.; Department of Primary Care and Public Health (Burr), Cardiff University, Wales, United Kingdom; and the Research Centre on Aging (Cunnane), Université de Sherbrooke, Sherbrooke, Que.

Correspondence to: Dr. David J.A. Jenkins, Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital, 61 Queen St. East, Toronto ON M5C 2T2; fax 416 978-5310; cyril.kendall{at}utoronto.ca

Background: A recent Cochrane meta-analysis did not confirm the benefits of fish and fish oil in the secondary prevention of cardiac death and myocardial infarction. We performed a meta-analysis of randomized controlled trials that examined the effect of fish-oil supplementation on ventricular fibrillation and ventricular tachycardia to determine the overall effect and to assess whether heterogeneity exists between trials.

Methods: We searched electronic databases (MEDLINE, EMBASE, The Cochrane Central Register of Controlled Trials, CINAHL) from inception to May 2007. We included randomized controlled trials of fish-oil supplementation on ventricular fibrillation or ventricular tachycardia in patients with implantable cardioverter defibrillators. The primary outcome was implantable cardioverter defibrillator discharge. We calculated relative risk [RR] for outcomes at 1-year follow-up for each study. We used the DerSimonian and Laird random-effects methods when there was significant heterogeneity between trials and the Mantel-Hanzel fixed-effects method when heterogeneity was negligible.

Results: We identified 3 trials of 1–2 years' duration. These trials included a total of 573 patients who received fish oil and 575 patients who received a control. Meta-analysis of data collected at 1 year showed no overall effect of fish oil on the relative risk of implantable cardioverter defibrillator discharge. There was significant heterogeneity between trials. The second largest study showed a significant benefit of fish oil (relative risk [RR] 0.74, 95% confidence interval [CI] 0.56–0.98). The smallest showed an adverse tendency at 1 year (RR 1.23, 95% CI 0.92–1.65) and significantly worse outcome at 2 years among patients with ventricular tachycardia at study entry (log rank p = 0.007).

Conclusion: These data indicate that there is heterogeneity in the response of patients to fish-oil supplementation. Caution should be used when prescribing fish-oil supplementation for patients with ventricular tachycardia.

This article has been cited by other articles:

				P. J Smith, J. A Blumenthal, M. A Babyak, A. Georgiades, A. Sherwood, M. H Sketch Jr, and L. L Watkins Association between n-3 fatty acid consumption and ventricular ectopy after myocardial infarction Am. J. Clinical Nutrition, May 1, 2009; 89(5): 1315 - 1320. [Abstract] [Full Text] [PDF]

				I. Mangat Do vegetarians have to eat fish for optimal cardiovascular protection? Am. J. Clinical Nutrition, May 1, 2009; 89(5): 1597S - 1601S. [Abstract] [Full Text] [PDF]

				I. A. Brouwer, M. H. Raitt, C. Dullemeijer, D. F. Kraemer, P. L. Zock, C. Morris, M. B. Katan, W. E. Connor, J. A. Camm, E. G. Schouten, et al. Effect of fish oil on ventricular tachyarrhythmia in three studies in patients with implantable cardioverter defibrillators Eur. Heart J., April 1, 2009; 30(7): 820 - 826. [Abstract] [Full Text] [PDF]

				D. J.A. Jenkins, J. L. Sievenpiper, D. Pauly, U. R. Sumaila, C. W.C. Kendall, and F. M. Mowat Are dietary recommendations for the use of fish oils sustainable? Can. Med. Assoc. J., March 17, 2009; 180(6): 633 - 637. [Full Text] [PDF]

				H. Leon, M. C Shibata, S. Sivakumaran, M. Dorgan, T. Chatterley, and R. T Tsuyuki Effect of fish oil on arrhythmias and mortality: systematic review BMJ, December 23, 2008; 337(dec23_2): a2931 - a2931. [Abstract] [Full Text] [PDF]

				H. Grundt and D. W.T. Nilsen n-3 fatty acids and cardiovascular disease Haematologica, June 1, 2008; 93(6): 807 - 812. [Full Text] [PDF]

				G. M. Nair MBBS MD and S. J. Connolly MD Should patients with cardiovascular disease take fish oil? Can. Med. Assoc. J., January 15, 2008; 178(2): 181 - 182. [Full Text] [PDF]

eLetters:

HOME	CURRENT ISSUE	PAST ISSUES	COLLECTIONS	HELP	SEARCH
Copyright 1995-2008, Canadian Medical Association. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p) All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association.